Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07203599) titled 'A Randomized Controlled Clinical Study on the Treatment of Androgenetic Alopecia in Young Men With Umbilical Cord Mesenchymal Stem Cell Exosomes' on Sept. 24.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Shenzhen People's Hospital
Condition:
Androgenic Alopecia
Intervention:
Drug: Human umbilical cord mesenchymal stem cell exosomes
Recruitment Status: Recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: September 20, 2025
Target Sample Size: 59
Countries of Recrui...